Article Information
History
- January 23, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Xinkai Li1,
- Joydeep Charkaborty2,
- Michael Jameson1,
- Hobert Moore3,
- Alexis Laux-Biehlmann4,
- Sikander Hayat5,6,* and
- Dhawal Jain4,*
- 1Data Integration and Historians Services, Enterprise Platforms and Infrastructure, Bayer US LLC., Pittsburgh, PA
- 2Product Platform Research, Enterprise Platforms and Infrastructure, Bayer US LLC., Morristown, NJ
- 3Infrastructure Engineering Services, Enterprise Platforms and Infrastructure, Bayer US LLC., Morristown, NJ
- 4Pulmonary Drug Discovery Laboratory, Bayer US LLC. Pharmaceuticals, Research & Development, Boston, MA
- 5Precision Cardiology Laboratory, Bayer US LLC. Pharmaceuticals, Research & Development, Boston, MA
- 6Institute of Experimental Medicine and Systems Biology, Uniklinik RWTH Aachen, Germany
- ↵*Corresponding author, email: hayat221{at}gmail.com